DXCM DEXCOM INC.

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

(NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) systems for people with diabetes, is teaming up with from around the globe to help raise awareness for the need to improve access to life-changing diabetes technology during National Diabetes Awareness Month in the U.S. and Canada (November) and on World Diabetes Day (November 14).

This press release features multimedia. View the full release here:

Dexcom Warriors from top left to right: Bambi B., Enrrique A., Nenad Š., Qiana D. & Lily D., Nick J.
Dexcom Warriors from bottom left to right: Natalie B., Victor G., Patti L., Hayley B., Steven C. (Photo: Business Wire)

Dexcom Warriors from top left to right: Bambi B., Enrrique A., Nenad Š., Qiana D. & Lily D., Nick J. Dexcom Warriors from bottom left to right: Natalie B., Victor G., Patti L., Hayley B., Steven C. (Photo: Business Wire)

To shine a spotlight on the daily battle of living with diabetes, Dexcom unveiled a first-of-its-kind, global portrait gallery that gives an honest but hopeful look at people living with diabetes from all walks of life as they navigate the highs and lows of living with an invisible disease.

Brought to life by creative director, Dexcom Warrior, and Australian model Bambi Northwood-Blyth, and photographed by renowned portrait photographer Fernando Sippel, features Dexcom Warriors from around the world, each living with Type 1 or Type 2 diabetes. Dexcom CGM users whose portraits appear in the gallery include:

• Beth McDaniel and Ellen Watson, Northern Irish best friends and students

• Leontine de Hollander, Netherlands photographer

• Christian Mansell, Australian motorsports racing driver

• MiYeong Kim, Korean author and diabetes activist

• Georgiana Dumitra, Romanian lifestyle and beauty content creator

• Nick Jonas, American multi-platinum recording artist, songwriter, actor and philanthropist

• Jeremy Irvine, English actor

• Patti LaBelle, American legendary GRAMMY-winning artist, actress, author and entrepreneur

• Laura Sabourin, Canadian high school teacher

• Victor Garber, Canadian-American actor and singer

“As a Dexcom Warrior living with diabetes, it’s an honor to bring to life this unfiltered and genuine representation of what life is like for the millions of people living with diabetes globally,” said Northwood-Blyth. “In addition to the powerful imagery, each portrait is paired with a deeply personal narrative that highlights the realities of living with diabetes, and how access to technology like Dexcom CGM can lessen the burden of this disease and greatly improve your quality of life.”

The #SeeDiabetes campaign and portrait gallery reinforces Dexcom’s worldwide commitment to broaden access to critical diabetes technology and is aligned with the theme for World Diabetes Day 2021-23, ‘Access to Diabetes Care.’ Elevating broad awareness for the latest diabetes management technology is an essential part of Dexcom’s ongoing efforts to increase access and reimbursement for CGM around the world.

Since Dexcom’s #SeeDiabetes access and awareness campaign last November, reimbursement coverage for CGM has expanded by 6 million people globally from 8 million to 14 million people with significant coverage expansions in the United States, Canada, France and Japan. In addition, Dexcom has brought previously unavailable CGM systems to market in nearly 20 countries around the world over the last 12 months.1

Despite this significant progress, millions more people with diabetes still face challenges obtaining coverage for the CGM systems they need to manage their condition more confidently. #SeeDiabetes: The Faces of Diabetes Warriors gives people with diabetes a unique platform to continue the global conversation about the need to improve access to critical diabetes care and technology.

“Awareness efforts like #SeeDiabetes, paired with clinical evidence that demonstrates the life-changing benefits of CGM, has led to the expansion of access to CGM for millions more people over the years,” said Dexcom president and CEO Kevin Sayer. “Dexcom is committed to working with healthcare providers, private payors, governments and nonprofit organizations around the world to significantly expand access to CGM for people with all Types of diabetes.”

To get involved in the conversation, Dexcom is asking people to visit and to share their own portrait and story of how diabetes has impacted them or someone they know using the hashtag #SeeDiabetes.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information on Dexcom, visit .

1 Dexcom, data on file, 2023

Category: IR

Dexcom, Dexcom Follow, Dexcom Clarity, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries. ©2023 Dexcom, Inc. All rights reserved.

EN
14/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEXCOM INC.

Dexcom Inc: 1 director

Two Directors at Dexcom Inc bought/sold 6,382 shares at between 0.000USD and 82.338USD. The significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...

Research Team ACF
  • Research Team ACF

KDST + NLSP Combined Core Investment Case 29052025

We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of merged metrics prior to any synergies. The merger creates a cross-platform pre-revenue biotech with lead programs including a proprietary stem-differentiation platform capable of delivering scalable therapies for replacing lost or damaged cells; IsletRx could revolutionize insulin production for Type 1 diabetes (T1D) patients; AstroRx® targets neurod...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

OSK OSHKOSH CORP
DXCM DEXCOM INC.
XRAY DENTSPLY SIRONA INC.
WING WINGSTOP INC.
VRTS VIRTUS INVESTMENT PARTNERS INC.
UHS UNIVERSAL HEALTH SERVICES INC. CLASS B
STKS ONE GROUP HOSPITALITY
SNPS SYNOPSYS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SFST SOUTHERN FIRST BANCSHARES
RGNX REGENXBIO INC.
RCKY ROCKY BRANDS
PRGO PERRIGO CO. PLC
MPWR MONOLITHIC POWER SYSTEMS INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
IRM IRON MOUNTAIN INC.
GPC GENUINE PARTS COMPANY
GD GENERAL DYNAMICS CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CROX CROCS INC.
CAL CALERES INC.
BKE BUCKLE INC.
ASC ARDMORE SHIPPING
AMOT ALLIED MOTION TECHNOLOGIES
ACAD ACADIA PHARMACEUTICALS INC.
SBL SAFE BULKERS INC.
LPG DORIAN LPG
MEG. MEG ENERGY CORP.
MDU MDU RESOURCES GROUP INC
NAT NORDIC AMERICAN TANKERS LIMITED
EVTC EVERTEC INC.
FSLR FIRST SOLAR INC.
IONS IONIS PHARMACEUTICALS INC.
NMIH NMI HOLDINGS INC. CLASS A
AGYS AGILYSYS INC.
SJM J.M. SMUCKER COMPANY
FIZZ NATIONAL BEVERAGE CORP.
NHC NATIONAL HEALTHCARE CORP.
INSW INTERNATIONAL SEAWAYS INC.
FLGT FULGENT GENETICS
DK DELEK US HOLDINGS INC
CELH CELSIUS HOLDINGS INC.
AMD ADVANCED MICRO DEVICES INC.
TTEC TTEC HOLDINGS INC.
AVGO BROADCOM INC.
ST SENSATA TECHNOLOGIES HOLDING PLC
ELAN ELANCO ANIMAL HEALTH INC.
MEC MAYVILLE ENGINEERING
DELL DELL TECHNOLOGIES INC CLASS C
CSTM CONSTELLIUM SE CLASS A
OI O-I GLASS INC
BWMN BOWMAN CONSULTING GROUP LTD
DINO HOLLYFRONTIER CORP
EVEX EVE HOLDING INC
SPXC SPX TECHNOLOGIES INC
WEST WESTROCK COFFEE COMPANY LLC
ADCT ADC THERAPEUTICS SA
SVV SAVERS VALUE VILLAGE INC
GUTS FRACTYL HEALTH INC
AGEN AGENUS INC.
ARDT ARDENT HEALTH PARTNERS INC
PCT PROVIDENT CAP TR II SKIS 8.75%29
MKTW MARKETWISE INC
 PRESS RELEASE

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medi...

EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East." The report surveyed over 2,500 people, made up of individuals with Type 2 diabetes and healthcare professionals, from Germany, Italy, the Netherlands, Saudi Arabia, Spain and the United Kingdom. The findings provide valuable insights into access to care and perceptions of diabetes technology. During the conference, first-ever accuracy a...

Research Team ACF
  • Research Team ACF

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innov...

Diabetes mellitus, Type 1 (T1D) and Type 2 (T2D, 85-90% of cases), is a USD ~75bn global therapy market. Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. In 2024, consensus global estimates suggested there were ~800m adult diabetes sufferers. In 2021, according to the IDF there >530m sufferers globally. For 2027E we modestly forecas...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch